Immunophotonics is excited to be featured in Pharma Tech Outlook magazine in the Immunotherapy edition.  Immunophotonics innovative approach could transform standard treatments into powerful immunotherapies with IP-001 turning every procedure into an opportunity to mobilize the body’s natural immune system against cancer.

“A New Frontier in Treating Cancer: The Great Potential of Interventional Immuno-Oncology™ Link to article